Nicola MASON,Daniel J. POWELL, Jr.,Mohammed Kazim PANJWANI,Jenessa SMITH
申请号：
US15743033
公开号：
US20190350972A1
申请日:
2016.07.08
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to compositions and methods for the treatment of a canine CD20 positive disease or condition using a canine CD20-specific chimeric antigen receptor. One aspect includes a modified canine T cells and pharmaceutical compositions comprising the modified cells for adoptive cell therapy and treating a disease or condition associated with enhanced immunity in canine.
